Healthcare Industry News: ESTECH
News Release - November 17, 2009
IDEV Technologies Names Christopher M. Owens President, Chief Executive OfficerWilliam W. Burke Appointed Executive Vice President, Chief Financial Officer
HOUSTON, Nov. 17 -- (Healthcare Sales & Marketing Network) -- IDEV Technologies, Incorporated (IDEV), an emerging leader in the development and marketing of minimally invasive medical technologies, today announced it has named Christopher M. Owens its President and Chief Executive Officer, effective immediately.
"Chris has a proven track record of results-based leadership and is the right person to take the Company to the next level," said Board Chairman Rick Anderson. "Chris has a clear vision and strategy of how we will advance IDEV through an explosive growth phase. We are confident and proud to have Chris leading the organization."
Mr. Owens has nearly 20 years of medical device experience holding senior-level executive positions in both the commercial and technical areas. Prior to coming to IDEV, he was Vice President of Worldwide Marketing for MicroVention from 2005-2008, a start-up medical device company that was purchased by Terumo Corporation. From 2003-2005, he was Vice President, Global Research and Development for the Surgical Division of Bausch & Lomb. Mr. Owens earned a bachelor's degree and a master's degree in Plastics Engineering from the University of Massachusetts, Lowell, and an MBA from the University of Phoenix.
The Company also appointed veteran medical device executive William W. Burke to Executive Vice President and Chief Financial Officer. Mr. Burke has more than 25 years of medical technology experience as a board member, senior executive and acquisition and financing advisor. He currently serves on the board of directors of Medical Action Industries, Inc. and Aperio Technologies, Inc. From 2004 through 2007, he was Executive Vice President and Chief Financial Officer of ReAble Therapeutics, Inc. From 2001 to 2004, he served as Chief Financial Officer of CholESTECH Corporation. Most recently, he served as President of Emergent Technologies, Inc. He earned a BBA in finance from the University of Texas at Austin and an MBA from The Wharton Graduate Business School at the University of Pennsylvania.
"Bill's extensive experience and capabilities as a CFO and healthcare executive will enable IDEV to accelerate our growth strategy," Mr. Anderson said. "We believe that Chris and Bill provide IDEV with an impressive combination of senior executive leadership, skills and experience. Under the leadership of these talented individuals, we look forward to a prosperous future."
"I believe we are building a strong foundation for growth and expansion for the treatment of biliary and peripheral artery disease," Mr. Owens said. "We have a robust technology portfolio and we will be expanding and leveraging our technologies into other markets, where it makes sense to do so."
In anticipation of future growth, IDEV has recently moved into an expanded, world-class facility in Webster, TX, Mr. Owens added.
About IDEV Technologies, Incorporated
IDEV Technologies, Incorporated (IDEV) is an innovator and developer of next generation medical devices for use in the interventional radiology, vascular surgery and cardiology device marketplace. IDEV worldwide headquarters is located in Webster, Texas with the European headquarters in Beuningen, Netherlands.
Source: IDEV Technologies
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.